Literature DB >> 24323809

Bone marrow chimeras in the study of experimental stroke.

Xian Nan Tang1, Zhen Zheng, Midori A Yenari.   

Abstract

Inflammation is known to contribute to stroke evolution, and poststroke immune responses have been documented to emanate from the brain via microglia. However, circulating immune cells are increasingly recognized to play a significant role as well. Recent work has demonstrated the importance of the peripheral circulation and stroke pathogenesis. Understanding how the peripheral circulation contributes to ischemic brain injury may reveal important therapeutic targets and strategies. The use of bone marrow chimeras can be a useful tool in understanding the relative contributions of brain resident and peripheral inflammatory responses.

Entities:  

Year:  2012        PMID: 24323809     DOI: 10.1007/s12975-012-0169-6

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  57 in total

1.  Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo.

Authors:  Vincent O Mallet; Claudia Mitchell; Eva Mezey; Monique Fabre; Jacques-Emmanuel Guidotti; Laurent Renia; Laure Coulombel; Axel Kahn; Hélène Gilgenkrantz
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production.

Authors:  Seok Joon Won; Xian Nan Tang; Sang Won Suh; Midori A Yenari; Raymond A Swanson
Journal:  Ann Neurol       Date:  2011-10-14       Impact factor: 10.422

Review 3.  The harms and benefits of inflammatory and immune responses in vascular disease.

Authors:  Angel Chamorro; John Hallenbeck
Journal:  Stroke       Date:  2006-01-12       Impact factor: 7.914

4.  Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Authors:  Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

5.  The spleen contributes to stroke-induced neurodegeneration.

Authors:  Craig T Ajmo; Dionne O L Vernon; Lisa Collier; Aaron A Hall; Svitlana Garbuzova-Davis; Alison Willing; Keith R Pennypacker
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

6.  Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy.

Authors:  M P Bowes; R Rothlein; S C Fagan; J A Zivin
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

7.  Apocynin improves outcome in experimental stroke with a narrow dose range.

Authors:  X N Tang; B Cairns; N Cairns; M A Yenari
Journal:  Neuroscience       Date:  2008-04-23       Impact factor: 3.590

8.  Hematopoietic stem cells engraft in untreated transplant recipients.

Authors:  D D Wu; A Keating
Journal:  Exp Hematol       Date:  1993-02       Impact factor: 3.084

9.  Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion.

Authors:  Hai Chen; Yun Seon Song; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-06       Impact factor: 6.200

10.  The HMGB1 receptor RAGE mediates ischemic brain damage.

Authors:  Sajjad Muhammad; Waleed Barakat; Stoyan Stoyanov; Sasidhar Murikinati; Huan Yang; Kevin J Tracey; Martin Bendszus; Grazisa Rossetti; Peter P Nawroth; Angelika Bierhaus; Markus Schwaninger
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

View more
  7 in total

Review 1.  The role of the microglia in acute CNS injury.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Metab Brain Dis       Date:  2014-03-29       Impact factor: 3.584

2.  Targeting the peripheral inflammatory response to stroke: role of the spleen.

Authors:  Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-09-26       Impact factor: 6.829

3.  Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.

Authors:  Kota Kurisu; Zhen Zheng; Jong Youl Kim; Jian Shi; Atsushi Kanoke; Jialing Liu; Christine L Hsieh; Midori A Yenari
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-07       Impact factor: 6.200

4.  ST2/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury.

Authors:  Yuanyuan Yang; Huan Liu; Haiyue Zhang; Qing Ye; Jianyi Wang; Boyu Yang; Leilei Mao; Wen Zhu; Rehana K Leak; Bo Xiao; Binfeng Lu; Jun Chen; Xiaoming Hu
Journal:  J Neurosci       Date:  2017-04-07       Impact factor: 6.167

Review 5.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

6.  Microglia and ischemic stroke: a double-edged sword.

Authors:  Anita R Patel; Rodney Ritzel; Louise D McCullough; Fudong Liu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

7.  Functional differences between microglia and monocytes after ischemic stroke.

Authors:  Rodney M Ritzel; Anita R Patel; Jeremy M Grenier; Joshua Crapser; Rajkumar Verma; Evan R Jellison; Louise D McCullough
Journal:  J Neuroinflammation       Date:  2015-05-29       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.